Increased Serum High-Molecular-Weight Complex of Adiponectin in Type 2 Diabetic Patients with Impaired Renal Function
Authors:
- Hirotaka KomabaHKHirotaka Komaba
- Naoya IgakiNINaoya Igaki
- Shunsuke GotoSGShunsuke Goto
- Kazuki YokotaKYKazuki Yokota
- Hisako DoiHDHisako Doi
- Toshiyuki TakemotoTTToshiyuki Takemoto
- Maki KohnoMKMaki Kohno
- Yoshiaki HirosueYHYoshiaki Hirosue
- Takeo GotoTGTakeo Goto
- 1 December 2006
- journal article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 26 (5) , 476-482
Abstract
Background/Aim: Adiponectin, an adipocyte-derived protein, has been shown to exert antidiabetic, anti-inflammatory, and antiatherosclerotic effects. Although recent reports show an increase in the total adiponectin levels in chronic kidney disease patients and in patients with end-stage renal disease, the nature of biodegradation and renal involvement of adiponectin is largely unknown. We aimed at determining whether the high-molecular-weight (HMW) complex of adiponectin is associated with renal insufficiency in type 2 diabetic patients. Methods: A total of 179 type 2 diabetic patients were selected from among outpatients and divided into four groups according to their albumin-to-creatinine ratio: patients with normoalbuminuria (n = 86), patients with microalbuminuria (n = 44), patients with macroalbuminuria (n = 23), and patients on hemodialysis (n = 26). The serum HMW adiponectin was specifically assayed with a commercially available enzyme-linked immunosorbent assay kit. Results: The HMW adiponectin levels were higher in patients on hemodialysis (17.1 ± 8.2 µg/ml) and in those with macroalbuminuria (14.3 ± 8.7 µg/ml) than in patients with normoalbuminuria (7.2 ± 5.6 µg/ml) and microalbuminuria (10.8 ± 7.0 µg/ml). Univariate linear regression analysis showed that the HMW adiponectin concentrations correlated negatively with the estimated glomerular filtration rate in patients with normoalbuminuria, microalbuminuria, and macroalbuminuria (r = –0.42, p < 0.001). Multiple stepwise regression analysis disclosed that estimated glomerular filtration rate, pioglitazone therapy, gender differences, and systolic blood pressure were independently associated with HMW adiponectin levels (r = 0.56). Conclusions: The serum HMW adiponectin concentrations are higher in type 2 diabetic patients with nephropathy, and these levels are also associated with renal insufficiency.Keywords
This publication has 30 references indexed in Scilit:
- Association between Plasma Adiponectin Concentration and Visceral Fat Accumulation in Hemodialysis PatientsNephron Clinical Practice, 2005
- PPARγ-Activating Angiotensin Type-1 Receptor Blockers Induce AdiponectinHypertension, 2005
- Blockade of the Renin-Angiotensin System Increases Plasma Adiponectin Levels in Type-2 Diabetic Patients with ProteinuriaNephron Clinical Practice, 2005
- Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal diseaseKidney International, 2004
- Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin SensitivityJournal of Biological Chemistry, 2004
- Impaired Multimerization of Human Adiponectin Mutants Associated with DiabetesJournal of Biological Chemistry, 2003
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003
- Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient MiceCirculation, 2002
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976